Nudging Preventive Screening Via Message Framing and Bundling
- Sponsor
- University of Chile
- Study ID
- NCT07644910
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Breast Neoplasms
- Colorectal Neoplasms
- Diabetes Mellitus
- Dyslipidemias
- Prostatic Neoplasms
- Uterine Cervical Neoplasms
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 74 Years
- Healthy Volunteers
- Not accepted
Interventions
- Basic cancer screening message — BEHAVIORALPatients receive a WhatsApp message naming their recommended cancer screening exam and describing it as the test recommended for their age group.
- Basic chronic disease test message — BEHAVIORALPatients receive a WhatsApp message naming the recommended chronic disease test and describing it as the test recommended for their age group.
- Basic combined message — BEHAVIORALPatients receive a WhatsApp message naming both the recommended cancer screening and the chronic disease test, and describing them as the tests recommended for their age group.
- Risk framing cancer screening message — BEHAVIORALPatients receive a WhatsApp message naming their recommended cancer screening exam and emphasizing that (1) the recommendation is based on health risks common to their age group and (2) early detection can be life-saving
- Risk framing chronic disease test message — BEHAVIORALPatients receive a WhatsApp message naming the recommended chronic disease test and emphasizing that (1) the recommendation is based on health risks common to their age group and (2) early detection can be life-saving.
- Risk framing combined message — BEHAVIORALPatients receive a WhatsApp message naming both exams and emphasizing that (1) the recommendation is based on health risks common to their age group and (2) early detection can be life-saving.
- Peace of mind framing cancer screening message — BEHAVIORALPatients receive a WhatsApp message naming their recommended cancer screening exam and emphasizing that getting the exam done on time will give them peace of mind about their health.
- Peace of mind framing chronic disease test message — BEHAVIORALPatients receive a WhatsApp message naming the recommended chronic disease and emphasizing that getting the exam done on time will give them peace of mind about their health.
- Peace of mind framing combined message — BEHAVIORALPatients receive a WhatsApp message naming both exams and emphasizing that getting the exams done on time will give them peace of mind about their health.
Study Details
This study is a randomized controlled field experiment embedded in the medical institution Early Diagnosis Program in Chile. Participants with two exams pending (a cancer screening test and a chronic disease test for diabetes and dyslipidemia) will be randomly assigned across a 3 × 3 factorial design: three message framing conditions (Basic, Risk/Importance, Peace of Mind) crossed with three exam-type conditions (cancer screening only, chronic disease test only, or both exams). Participants with only a cancer screening pending will be assigned to the 3 framing conditions and be encouraged to get the cancer screening. In both cases, participants are assigned to each experimental arm at twice the rate of an additional arm receiving the standard message currently used by the medical institution. This standard-message arm is included for operational purposes, is not part of the pre-specified analyses, and is thus not described in the "Arms and Intervention" section (or counted for "number of arms").
Key Dates
- First listed
- Jun 12, 2026
- Start date
- Jun 8, 2026
- Status verified
- Jun 2026
- Primary completion
- Sep 8, 2026
- Completion
- Dec 8, 2026
Study Design
- Enrollment
- 235,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Active Comparator: Basic/Control × CancerBasic cancer screening message
- Active Comparator: Basic/Control × chronic disease testBasic chronic disease test message
- Active Comparator: Basic/Control × BothBasic combined message
- Experimental: Risk/Importance × CancerRisk framing cancer screening message
- Experimental: Risk/Importance × Chronic Disease TestRisk framing chronic disease test message
- Experimental: Risk/Importance × BothRisk framing combined message
- Experimental: Peace of Mind × Cancer screeningPeace of mind framing cancer screening message
- Experimental: Peace of Mind × chronic disease TestPeace of mind framing chronic disease test message
- Experimental: Peace of Mind × BothPeace of mind framing combined message
Primary Outcome Measure
Screening Engagement Response [ Time Frame: 7 days after message delivery ]
Central Contacts
- Daniel Schwartz Associate Professor, Department of Industrial Engineering, Ph.D. Behavioral Decision+56979984165
Find similar trials
Related Studies
- Genetic Studies of Insulin and DiabetesRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer CellsRecruiting · Washington University School of Medicine · St Louis, Missouri
- Prostate Active Surveillance StudyRecruiting · University of Washington · San Francisco, California
- Collection of Blood From Patients With Prostate CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland